Here’s What Makes AptarGroup (ATR) a Long-Term Holding

1 month ago 24

Soumya Eswaran

Mon, February 16, 2026 astatine 8:03 AM CST 3 min read

Aristotle Capital Boston, LLC, an concern advisor, released its fourth-quarter capitalist missive for “Small Cap Equity Fund”. A transcript of the missive tin beryllium downloaded here. U.S. small-cap equities reported humble gains successful the 4th fourth of 2025. The 4th started arsenic a continuation of the post-Liberation Day risk-on marketplace environment, portion it ended connected a beardown note, driven by a affirmative macroeconomic backdrop. Attractive valuations, net recovery, broadening of the market, and a displacement from mega-cap stocks supported tiny caps successful the quarter. The Aristotle Small Cap Equity Fund (Class I-2) returned 1.96% successful Q4 2025, trailing the 2.19% full instrumentality of the Russell 2000 Index. Security enactment supported wide performance, portion allocation effects detracted from performance. Please reappraisal the Strategy’s apical 5 holdings to summation insights into their cardinal selections for 2025.

In its fourth-quarter 2025 capitalist letter, Aristotle Small Cap Equity Fund highlighted AptarGroup, Inc. (NYSE:ATR) arsenic a caller summation to its portfolio. AptarGroup, Inc. (NYSE:ATR) is simply a starring healthcare institution that focuses connected cause delivery, user merchandise dispensing, and progressive worldly subject solutions and services. On February 13, 2026, AptarGroup, Inc. (NYSE:ATR) banal closed astatine $142.58 per share. One-month instrumentality of AptarGroup, Inc. (NYSE:ATR) was 14.33%, and its shares are down 1.53% implicit the past 12 months. AptarGroup, Inc. (NYSE:ATR) has a marketplace capitalization of $9.356 billion.

Aristotle Small Cap Equity Fund stated the pursuing regarding AptarGroup, Inc. (NYSE:ATR) successful its 4th fourth 2025 capitalist letter:

"AptarGroup, Inc. (NYSE:ATR) is simply a planetary packaging institution focused connected the plan and manufacturing of dosing, dispensing, and extortion technologies, serving aggregate industries, including pharmaceutical, beauty, idiosyncratic care, location care, and nutrient and beverage. A operation of a cyclical rebound successful request positive the maturation and fiscal benefits of the company’s continued concern successful its pharmaceutical products part should presumption the institution to make shareholder worth implicit the adjacent respective years."

The Unsung Hero of Reliable Dividend Growth

AptarGroup, Inc. (NYSE:ATR) is not connected our database of 30 Most Popular Stocks Among Hedge Funds. According to our database, 29 hedge money portfolios held AptarGroup, Inc. (NYSE:ATR) astatine the extremity of the 3rd quarter, the aforesaid arsenic successful the erstwhile quarter. In the 4th fourth ended December 31,2025, AptarGroup, Inc.'s (NYSE:ATR) reported income accrued 14% to $963 million. While we admit the imaginable of AptarGroup, Inc. (NYSE:ATR) arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

Read Entire Article